252 related articles for article (PubMed ID: 25686827)
1. Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.
Kopecka J; Campia I; Jacobs A; Frei AP; Ghigo D; Wollscheid B; Riganti C
Oncotarget; 2015 Mar; 6(9):6776-93. PubMed ID: 25686827
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors.
Kopecka J; Rankin GM; Salaroglio IC; Poulsen SA; Riganti C
Oncotarget; 2016 Dec; 7(52):85861-85875. PubMed ID: 27811376
[TBL] [Abstract][Full Text] [Related]
3. Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma.
Salaroglio IC; Mujumdar P; Annovazzi L; Kopecka J; Mellai M; Schiffer D; Poulsen SA; Riganti C
Mol Cancer Ther; 2018 Dec; 17(12):2598-2609. PubMed ID: 30254183
[TBL] [Abstract][Full Text] [Related]
4. An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo.
von Neubeck B; Gondi G; Riganti C; Pan C; Parra Damas A; Scherb H; Ertürk A; Zeidler R
Int J Cancer; 2018 Oct; 143(8):2065-2075. PubMed ID: 29786141
[TBL] [Abstract][Full Text] [Related]
5. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.
Lounnas N; Rosilio C; Nebout M; Mary D; Griessinger E; Neffati Z; Chiche J; Spits H; Hagenbeek TJ; Asnafi V; Poulsen SA; Supuran CT; Peyron JF; Imbert V
Cancer Lett; 2013 Jun; 333(1):76-88. PubMed ID: 23348702
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.
Vaeteewoottacharn K; Kariya R; Dana P; Fujikawa S; Matsuda K; Ohkuma K; Kudo E; Kraiklang R; Wongkham C; Wongkham S; Okada S
Tumour Biol; 2016 Jul; 37(7):9023-35. PubMed ID: 26762407
[TBL] [Abstract][Full Text] [Related]
8. Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
Podolski-Renić A; Dinić J; Stanković T; Jovanović M; Ramović A; Pustenko A; Žalubovskis R; Pešić M
Eur J Pharm Sci; 2019 Oct; 138():105012. PubMed ID: 31330259
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
[TBL] [Abstract][Full Text] [Related]
10. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells.
Teodori E; Braconi L; Bua S; Lapucci A; Bartolucci G; Manetti D; Romanelli MN; Dei S; Supuran CT; Coronnello M
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290281
[TBL] [Abstract][Full Text] [Related]
11. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
[TBL] [Abstract][Full Text] [Related]
12. Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents.
Alafeefy AM; Ahmad R; Abdulla M; Eldehna WM; Al-Tamimi AM; Abdel-Aziz HA; Al-Obaid O; Carta F; Al-Kahtani AA; Supuran CT
Eur J Med Chem; 2016 Feb; 109():247-53. PubMed ID: 26774930
[TBL] [Abstract][Full Text] [Related]
13. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
Robertson N; Potter C; Harris AL
Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
Chen Z; Ai L; Mboge MY; Tu C; McKenna R; Brown KD; Heldermon CD; Frost SC
PLoS One; 2018; 13(7):e0199476. PubMed ID: 29965974
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.
Gondi G; Mysliwietz J; Hulikova A; Jen JP; Swietach P; Kremmer E; Zeidler R
Cancer Res; 2013 Nov; 73(21):6494-503. PubMed ID: 24030978
[TBL] [Abstract][Full Text] [Related]
18. Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.
Gelsomino G; Corsetto PA; Campia I; Montorfano G; Kopecka J; Castella B; Gazzano E; Ghigo D; Rizzo AM; Riganti C
Mol Cancer; 2013 Nov; 12():137. PubMed ID: 24225025
[TBL] [Abstract][Full Text] [Related]
19. RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells.
Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Mol Cancer Res; 2008 Oct; 6(10):1607-20. PubMed ID: 18922976
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
